We were pleased to host a delegation from Blockchain For Impact (BFI), led by its CEO Dr. Gaurav Singh, at the UPPPC office, where the team held a productive discussion with Ms. Kritika Sharma, IAS, MD & CEO, UPPPC.
The meeting focused on exploring strategic partnerships under the UP MedTech Launcher Programme, accelerating research, innovation, and entrepreneurship in the MedTech ecosystem, and identifying avenues for future collaboration to strengthen Uttar Pradesh's position as a leading hub for healthcare innovation and technology-driven solutions.
UPPPC remains committed to fostering impactful partnerships that drive innovation, support startups, and contribute to the vision of a self-reliant and globally competitive MedTech ecosystem in Uttar Pradesh.
@CMOfficeUP @UPGovt @AwasthiAwanishK @Vhzhimomi @mededuup @Seceratary81571 @kritika191290 @InvestInUP @BlockchainforImpact @InvestUP_India @BFI_Impact
#UPPPC #UPMedTechLauncher #MedTech #HealthcareInnovation #ResearchAndDevelopment #HealthTech #MedTechStartups #InvestUP #BFI #BlockchainForImpact #UPInnovation #MakeInIndia
Strengthening Uttar Pradesh’s position as a leading pharmaceutical investment destination. Uttar Pradesh Promote Pharma Council (UPPPC), in association with Invest UP, conducted virtual meetings with 16 prospective investors on 5–6 November 2026 to facilitate the progression of investment proposals toward implementation.
The discussions focused on project profiles, product portfolios, land requirements and financial preparedness to assess investor readiness for issuance of Land Facilitation Letters to eligible investors.
UPPPC remains committed to fast-tracking investment proposals, enabling timely facilitation, and ensuring the conversion of investment intents into on-ground projects that contribute to employment generation, industrial growth and economic development in Uttar Pradesh.
@CMOfficeUP @UPGovt @AwasthiAwanishK @Vhzhimomi @mededuup @Seceratary81571 @kritika191290 @InvestInUP
#UPPPC #InvestUP #InvestInUP #InvestmentPromotion #PharmaIndustry #BulkDrugs #MedicalDevices #LifeSciences #PharmaceuticalManufacturing #IndustrialDevelopment #EaseOfDoingBusiness #HealthcareInnovation
Transforming Clinical Research in Uttar Pradesh through Digital Innovation!
UP-IMRAS (Integrated Medical Research Application System), an initiative of the Uttar Pradesh Promote Pharma Council (UPPPC), is building a unified, AI-enabled digital ecosystem to streamline clinical research across the state.
Key Achievements:
🔹 90+ institutions onboarded
🔹 4,936 Principal Investigators
🔹 2,521 students onboarded
🔹 1,450+ research protocols submitted
With AI-enabled validation, unified digital payments, single-window approvals, real-time tracking and fast-track Ethics Committee reviews, UP-IMRAS is advancing transparency, efficiency and compliance in clinical research.
Together, we are building a stronger, smarter and globally aligned medical research ecosystem in Uttar Pradesh!
@UPGovt @_InvestUP @InfoDeptUP @drreddys @Pharma_Mankind @Seceratary81571 @kritika191290 @Vhzhimomi @mededuup
#UPPPC #UPIMRAS #ClinicalResearch #ClinicalTrials #MedicalResearch #HealthcareInnovation #DigitalGovernance #ResearchExcellence #UttarPradesh #InvestInUP
77
In line with the Government of Uttar Pradesh’s vision to strengthen the state’s pharmaceutical and medical device ecosystem the Business Development Team of the Uttar Pradesh Promote Pharma Council (UPPPC) held a virtual interaction with M/s S.D. Biosensor, facilitated by the Association of Diagnostic Manufacturers of India (ADMI), to explore opportunities for investment and growth in Uttar Pradesh’s medical devices sector.
During the discussion, M/s S.D. Biosensor shared its potential investment plan of ₹100 crore in the state, focusing on the in-vitro diagnostics (IVD) and point-of-care testing (POCT) segments. The proposed investment could contribute to strengthening local manufacturing capacity, supporting the growth of the medical devices ecosystem, and creating new opportunities across the sector.
UPPPC reaffirmed its commitment to engaging with industry partners and facilitating investment in Uttar Pradesh through information, coordination and support for potential investors.
@UPGovt @AwasthiAwanishK @Vhzhimomi @mededuup @Seceratary81571 @kritika191290 @SDBIOSENSOR_PR @Diagnostic58962
#UPPPC #UttarPradesh #MedicalDevices #IVD #POCT #InvestmentPromotion
51
In line with UP Promote Pharma Council mission, to position Uttar Pradesh as India's premier hub for healthcare manufacturing, the UPPPC Business Development Team successfully concluded a high-impact, two-day strategic visit to the National Capital Region (NCR) on 27–28 October 2026.
With a focus on accelerating investments into Uttar Pradesh’s rapidly expanding pharmaceutical and medical device sectors, the UPPPC BD Team engaged deeply with six anchor medical device manufacturers.
Key highlights of the interactions included:
-Evaluating cutting-edge manufacturing facilities & diverse product portfolios.
-Assessing immediate and future investment blueprints & critical regulatory/infrastructure requirements.
-Unlocking high-value investment leads & untapped market opportunities.
-Strengthening industry linkages to robustly expand UP’s long-term investment pipeline.
UPPPC remains committed to offering a world-class ecosystem, robust infrastructure, and seamless facilitation for global and domestic healthcare leaders looking to scale in Uttar Pradesh.
@Seceratary81571 @kritika191290 @Vhzhimomi @mededuup @UPGovt @UPSIDA @_InvestUP @Yamunaresidents
#UPPPC #UttarPradesh #MedicalDevices #Pharma #InvestmentPromotion #MakeInUP #HealthcareInfrastructure #BusinessDevelopment
1
72
UP Promote Pharma Council held a virtual meeting with the Blockchain for Impact (BFI)– Nailwal MedTech Acceleration Hub (NAMAH) team on 28 October 2026 to discuss opportunities for collaboration under the MedTech Launcher Programme .
The discussion focused on how UP Promote Pharma Council can help strengthen Uttar Pradesh’s MedTech ecosystem by supporting promising innovations and startups at TRL 7–9 — bridging the journey from advanced development and validation to scale-up and commercialization. The proposed collaboration could connect innovators with relevant ecosystem support and help advance impactful MedTech solutions for the state.
@BFI_Impact @Seceratary81571 @kritika191290 @Vhzhimomi @mededuup @CDSCO_INDIA_INF @UPGovt
#UPPPC #NAMAH #BFI #MedTech #UttarPradesh #Innovation #Startups
🤖 Made with AI
54
From Lab to Market: Advancing Biotechnology in Uttar Pradesh!
Under the visionary leadership of Ms. Kritika Sharma, IAS, MD & CEO, UPPPC, the Uttar Pradesh Promote Pharma Council is spearheading the establishment of a State-level BioE3 Cell to accelerate biotechnology research, foster innovation and strengthen industry–academia collaboration.
The initiative brings together experts from leading institutions:
CSIR-CDRI — Dr. Ravishankar Ramchandran, Scientist-G
IIT (BHU), Varanasi — Dr. Pranjal Chandra, Associate Professor
CBMR, Lucknow — Dr. Syed Masood Hussain, Associate Professor
CSIR-IICT — Dr. Rajneesh Kumar Chaturvedi, Scientist-G
NIPER, Raebareli — Dr. Ravindra Kumar Kaudal, Assistant Professor
IIT Kanpur — Prof. J. Ramkumar
Prof. Sandeep Sharma, GM (Research & Innovation), UPPPC , will coordinate the initiative, fostering collaboration to translate research into market-ready solutions.
The proposed BioE3 Cell aims to advance sustainable biotechnology, promote technology transfer, generate employment and strengthen Uttar Pradesh’s innovation-driven biotech ecosystem, in alignment with the Government of India’s BioE3 vision.
@CSIR_CDRI @cbmrofficial @csiriict @NIPERRaebareli @CSIR_IND @IITBHU_Official @IITKanpur @DBTIndia @Seceratary81571 @kritika191290 @Vhzhimomi @mededuup @AwasthiAwanishK @CSIR_NIScPR @UPGovt
#UPPPC #BioE3 #Biotechnology #ResearchToMarket #Innovation #UttarPradesh
56
The Business Development (BD) Vertical of UPPPC is driving pharma & medical device investments in Uttar Pradesh, securing ₹1,500+ Cr in medical device and ₹150+ Cr in pharma investment intents, with ₹1,200+ Cr in MoUs signed and land facilitation letters issued.
Further, ₹1,200+ Cr in potential investments from anchor investors is in the pipeline. Engagement with 7 medical device associations is connecting UPPPC with 350+ industry players pan-India.
UPPPC is also facilitating the proposed relocation of the 83-member AiMeD–SMTA medical device industry cluster adjacent to YEIDA Medical Device Park, in coordination with CEO, YEIDA, for land allotment and establishment of manufacturing units.
UP Promote Pharma Council: Driving investments, strengthening industry linkages, and positioning Uttar Pradesh as a leading pharma & medical device manufacturing hub.
#UPPPC #InvestUP #Pharma #MedicalDevices #UttarPradesh #InvestmentFacilitation
65
The Business Development (BD) Vertical of UPPPC is driving pharma & medical device investments in Uttar Pradesh, securing ₹1,500+ Cr in medical device and ₹150+ Cr in pharma investment intents, with ₹1,200+ Cr in MoUs signed and land facilitation letters issued.
Further, ₹1,200+ Cr in potential investments from anchor investors is in the pipeline. Engagement with 7 medical device associations is connecting UPPPC with 350+ industry players pan-India.
UPPPC is also facilitating the proposed relocation of the 83-member AiMeD–SMTA medical device industry cluster adjacent to YEIDA Medical Device Park, in coordination with CEO, YEIDA, for land allotment and establishment of manufacturing units.
UP Promote Pharma Council: Driving investments, strengthening industry linkages, and positioning Uttar Pradesh as a leading pharma & medical device manufacturing hub.
#UPPPC #InvestUP #Pharma #MedicalDevices #UttarPradesh #InvestmentFacilitation
57
UPPPC Strengthens Investor Facilitation in Uttar Pradesh!
As part of its commitment to investor handholding, UPPPC facilitated a meeting on 20 September 2026 between the Vice Chairman, LDA, and the CEO of Varisha Life Sciences to address land-use conversion requirements for its proposed manufacturing facility.
The project aims to develop capabilities in anticancer drug formulations, innovative therapies and oral film technology. Remedial measures were suggested by the VC, LDA, to facilitate commercial land-use conversion, paving the way for the proposed unit to be established within the next two months.
UPPPC remains committed to streamlining investor facilitation, enabling pharmaceutical investments and strengthening UP’s life sciences ecosystem .
#UPPPC #InvestUP #Pharma #LifeSciences #InvestorFacilitation #EaseOfDoingBusiness #UttarPradesh
43
UPPPC Honored with the Prestigious SKOCH Award 2026.
Uttar Pradesh Promote Pharma Council (UPPPC) has been conferred the prestigious SKOCH Award 2026 in the Ease of Doing Business category for its Uttar Pradesh Integrated Medical Research Application System (UP-IMRAS).
The award was received by Prof. Sandeep Sharma, GM (Research & Innovation), on behalf of MD & CEO, UPPPC, Ms. Kritika Sharma, IAS, at a ceremony in New Delhi.
This recognition highlights UPPPC's commitment to advancing digital innovation, transparency and ease of doing business in the pharma and healthcare sectors of Uttar Pradesh.
Explore more about UPPPC (uppromotepharmacouncil.org/) &
UP-IMRAS (uppromotepharmacouncil.org/u…)
#UPPPC #SKOCHAward2026 #UPIMRAS #HealthcareInnovation #UttarPradesh
Strengthening Clinical Research in Uttar Pradesh.
UP Promote Pharma Council officials held a discussion with Indian Council of Medical Research (ICMR) officials to advance the State’s clinical research ecosystem.
Key aspects were:
~ Onboarding Medical Colleges on ICMR INTENT
~ Expanding GCP capacity-building
The discussions reinforced a shared commitment to enhance institutional research capacity, streamline clinical research processes and foster a robust, transparent & globally aligned research ecosystem in UP.
@ICMRDELHI @MoHFW_INDIA @UPGovt @UPGovtHealth
#UPPPC #ICMR #ClinicalResearch #ClinicalTrials #UPIMRAS #UPSHRUTI #GCP #MedicalResearch #HealthcareInnovation #UttarPradesh
2
81
Advancing Clinical Research in Uttar Pradesh
UP Promote Pharma Council (UPPPC), Government of Uttar Pradesh, in collaboration with the Indian Society for Clinical Research (ISCR), organised a one-day webinar on UP-IMRAS, bringing together 300+ participants from across India representing industry, academia, CROs and regulatory affairs.
The session featured an overview and live demonstration of UP-IMRAS, followed by an interactive discussion and Q&A, facilitating wider awareness and stakeholder engagement towards a transparent, efficient and digitally enabled clinical research ecosystem in Uttar Pradesh.
#UPPPC #UPIMRAS #ISCR #ClinicalResearch #ClinicalTrials #MedicalResearch #HealthcareInnovation #UttarPradesh
1
62
UPIMRAS Excellence Leaderboard - 15 Sep 2026
The Government of Uttar Pradesh recognises outstanding contributions towards strengthening Clinical Research and Evidence-Based Healthcare across the State
TOP INSTITUTE in Academic Studies
Sarojini Naidu Medical College, Agra
162 Studies *Academic Studies: 157
*Clinical Trials: 05
TOP INSTITUTE in Clinical Studies
Ganesh Shankar Vidyarthi Memorial Medical
College, Kanpur (GSVM) - 13 Studies
TOP RESEARCHER in Academic Studies
Dr. Ritu Sharma - 13 Studies
Professor (Obs & Gynae),
Government Institute of Medical Sciences,
G. Noida
TOP RESEARCHER in Clinical Studies
Dr. Santosh Kumar Sinha - 03 Studies
Professor (Cardiology),
LPS Institute of Cardiology & Cardiac Surgery,
Kanpur
TOP ETHICS COMMITTEE - 22 Studies Approved
Rohilkhand Medical College & Hospital, Bareilly
* Academic Studies: 22 * EC Meeting Schedule Pending: 03
Congratulations to all the institutions, researchers and Ethics Committee members for their outstanding contribution towards strengthening clinical research and evidence-based healthcare in UP.
The Government remains committed to promoting quality clinical research, innovation and evidence-based healthcare for a healthier and stronger Uttar Pradesh.
#UPIMRAS #ClinicalResearch #ResearchExcellence #HealthUP #UttarPradesh
1
6
148
Strengthening India–US cooperation in healthcare and life sciences.
The Uttar Pradesh Promote Pharma Council (UPPPC) under the guidance of MD & CEO Ms Kritika Sharma, IAS, hosted the India–US Healthcare & Life Sciences Business & Investment Dialogue in Taj Palace, Lucknow in the gracious presence of @AmitGhoshIAS, Dr GN Singh sir, @NehaSharmaIAS, @rituias2003 bringing together senior Government officials, industry leaders and representatives of leading US institutions.
Deliberations focused on investment, technology transfer, R&D, manufacturing and strategic partnerships to strengthen the healthcare and life sciences ecosystem in Uttar Pradesh.
A key milestone was the signing of an MoU between UPPPC and the Indo-American Chamber of Commerce (IACC) to facilitate investment, collaboration and business opportunities in Uttar Pradesh. @iaccindia @ExportGov @USCSIndia
#UPPPC #UttarPradesh #IndiaUS #Healthcare #LifeSciences #Investment #Pharma #MedicalDevices #InvestInUP #UPIMRAS
2
153
CAREER OPPORTUNITY in UPPPC
Uttar Pradesh Promote Pharma Council (UPPPC) invites applications for various Assistant Manager positions i.e. Finance, Investment & Grants, Human Resource, Business Development & Investment (Biopharma & Related), Business Development & Investment (Technology & Medical Devices)
Last date: Within 28 days from the date of publication.
#UPPPC #Recruitment #Pharma #UttarPradesh #Jobs #Medtech
3
91
The 3rd BioE3 Working Group Meeting was held on 9th Sep 2026 at UPPC Office at Lal Bahadur Shastri Bhawan, Lucknow, focusing on strengthening Uttar Pradesh’s bioeconomy ecosystem.
Key discussions included the pre-finalization of the DPR, Hub-and-Spoke model, anchor institutions, budget & funding, 5-year implementation plan, measurable KPIs, sustainability, and governance & monitoring mechanisms.
The Working Group also reviewed outcomes from institutional consultations covering biotherapeutics & precision medicine, waste-to-health/biomass, and medical devices & emerging technologies.
#BioE3 #UttarPradesh #BioEconomy #Biotechnology #Innovation #UPPPC #Healthcare #MedTech
A significant step towards strengthening Uttar Pradesh’s advanced medical-device manufacturing ecosystem.
On 08 September 2026, Uttar Pradesh Promote Pharma Council (UPPPC), Lucknow, along with the SS Innovation team, held an investor facilitation meeting with the CEO, YEIDA, ACEO and senior officials at the YEIDA Office, Greater Noida.
Discussions focused on facilitating SS Innovation’s proposed R&D & manufacturing setup for advanced robotic surgical devices at the YEIDA Medical Device Park, with an envisaged investment of ₹800+ Cr in Phase-I and ₹5,000+ Cr over 5 years.
The project is poised to strengthen India’s medical-device ecosystem, promote import substitution, create skilled employment and enhance UP’s position as a hub for advanced medical-device innovation and manufacturing.
#UPPPC #YEIDA #MedicalDevices #RoboticSurgery #InvestInUP #UttarPradesh #MakeInIndia #ClinicalResearch #HealthcareInnovation #UttarPradesh
2
117


















